from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0765c/-

LFCtreatmentdescriptionclass of inhibitor

-0.708

Amikacinug/mL Amikacintranslation

-1.066

Cap5-10ug/mL Capreomycintranslation

-0.569

Rox10-50 ug/mL Roxithromycintranslation

-1.028

SM2-5 ug/mL Streptomycintranslation

-0.091

Tet5-10 ug/mL Tetracyclinetranslation

0.609

Rif0.2-5ug/mL Rifampicintranscription

0.088

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.286

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.198

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.090

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.563

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.150

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.427

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.400

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.011

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

3.265

NaN30.2-2 mM Sodium aziderespiration

-0.061

Nigericin50 uM Nigericinrespiration

1.321

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.851

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.593

menadione6-10 ug/mL Menadionerespiration

0.487

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.249

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.196

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.445

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.506

NRP_1Non-replicating persistence stage 1dosRassociated

-0.565

Amp0.2mg/mL AmpicillincellWall

-0.285

Cephalexin20-100 ug/mL CephalexincellWall

-0.386

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.489

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.518

EMB10-20 ug/mL EthambutolcellWall

0.058

Eta12-40 ug/mL EthionamidecellWall

-0.592

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.265

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.303

BZA0.12 mg/mL BenzamidearomaticAmides

0.331

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.145

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.006

H2O24 mM hydrogen peroxideDNAdamaging

-0.193

Levo10 ug/mL LevofloxacinDNAdamaging

-0.526

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.474

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.536

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.058

Antimycin12.5-50 ug/mL Antimycin A?

-1.600

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.096

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.371

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.455

PA8240.2-2 ug/mL PA-824?

0.122

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.440

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.294

Verapamil50 uM Verapamil?

1.885

mercaptoethanol2 mM 2-Mercaptoethanol?

2.333

methoxatin10-20 ug/mL Methoxatin?